Recent many studies showed that HES1 overexpression resulted in chemoresistance in lung cancers, intestine cancers, and pancreatic cancers owing to elevating stemness properties acquisition 8, 10, 11. This evidence concerns the gene HES1 and familial pancreatic carcinoma.